Get Started

IMMP

Immutep (IMMP)

Immutep Ltd

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:IMMP

<< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >>

Date	Time	Source	Headline	Symbol	Company
09/28/2018	6:08AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
09/27/2018	4:36AM	GlobeNewswire Inc.	Edison issues update on Immutep (IMMX)	NASDAQ:IMMP	Immutep Ltd
09/10/2018	6:10AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
09/05/2018	6:06AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
08/24/2018	6:09AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
08/17/2018	6:12AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
08/08/2018	6:11AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
08/01/2018	6:06AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
07/31/2018	6:20AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
07/03/2018	6:15AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
07/02/2018	8:00AM	GlobeNewswire Inc.	Immutep Submits Investigational New Drug (IND) Application With FDA	NASDAQ:IMMP	Immutep Ltd
06/20/2018	6:07AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
06/05/2018	6:09AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
05/31/2018	7:03AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
05/30/2018	8:00AM	GlobeNewswire Inc.	Positive New Data from Ongoing TACTI-mel Study in Unresectable or Metastatic Melanoma Presented in Global Webcast	NASDAQ:IMMP	Immutep Ltd
05/30/2018	6:14AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
05/18/2018	6:04AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
05/17/2018	8:00AM	GlobeNewswire Inc.	Immutep to Present Interim Results from TACTI-mel Clinical Trial in Global Webcast	NASDAQ:IMMP	Immutep Ltd
05/07/2018	10:15AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
05/04/2018	4:00AM	GlobeNewswire Inc.	Immutep to Present at 2018 ASCO Annual Meeting	NASDAQ:IMMP	Immutep Ltd
04/26/2018	6:10AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
04/13/2018	5:27PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
04/13/2018	5:23PM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
04/12/2018	9:24PM	GlobeNewswire Inc.	Immutep Completes A$6.31 Million Share Purchase Plan; Raises Total of A$13.16 Million	NASDAQ:IMMP	Immutep Ltd
04/04/2018	6:06AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
04/02/2018	8:38PM	GlobeNewswire Inc.	Operational Update	NASDAQ:IMMP	Immutep Ltd
03/23/2018	6:07AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd
03/22/2018	7:45PM	GlobeNewswire Inc.	Updated TACTI-mel Data Presented at the Cambridge Healthtech Institute’s Immuno-Oncology Summit	NASDAQ:IMMP	Immutep Ltd
03/21/2018	6:29PM	GlobeNewswire Inc.	Immutep Commences Patient Dosing in Additional TACTI-mel Cohort	NASDAQ:IMMP	Immutep Ltd
03/20/2018	6:09AM	Edgar (US Regulatory)	Report of Foreign Issuer (6-k)	NASDAQ:IMMP	Immutep Ltd